Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 GeneticVariation group BEFREE Vanishing white matter disease (VWM) is an inherited leukoencephalopathy in children attributed to mutations in EIF2B1-5, encoding five subunits of eukaryotic translation initiation factor 2B (eIF2B). 30720246 2019
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 GeneticVariation group BEFREE Mutations in eIF2B encoded by EIF2B1-5 cause a lethal leukoencephalopathy--vanishing white matter disease (VWM). 26625702 2016
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 GeneticVariation group BEFREE Vanishing white matter disease is caused by mutations of the eukaryotic translation initiation factor 2B (EIF2B) and is a prevalent cause of inherited childhood leukoencephalopathy. 24938145 2014
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 Biomarker group BEFREE Autosomal recessive mutations in eukaryotic initiation factor 2B (eIF2B) cause leukoencephalopathy vanishing white matter with a wide clinical spectrum. eIF2B comprises five subunits (α-ε; genes EIF2B1, 2, 3, 4 and 5) and is the guanine nucleotide-exchange factor (GEF) for eIF2. 21560189 2011
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 GeneticVariation group BEFREE It is surprising that mutations in the eIF2B genes have been reported to lead to abnormalities of the white matter of the brain only, although it has been shown recently that ovarian failure may accompany the leukoencephalopathy. 14566705 2003
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 GeneticVariation group BEFREE Childhood ataxia with central hypomyelination (CACH)/vanishing white matter (VWM) leukoencephalopathy is related to mutations in all five genes of the eukaryotic translation initiation factor (eIF2B). 12499492 2002
CUI: C0270612
Disease: Leukoencephalopathy
Leukoencephalopathy
0.160 Biomarker group HPO